Insulet
PODD
#1049
Rank
A$32.26 B
Marketcap
A$458.41
Share price
-3.62%
Change (1 day)
10.50%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2025 (TTM): A$0.56 Billion

According to Insulet's latest financial reports the company's current earnings are A$2.52 Billion. In 2024 the company made an earning of A$0.51 Billion, an increase over its 2023 earnings that were of A$0.37 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$0.56 B9.84%
2024 A$0.51 B36.72%
2023 A$0.37 B481.9%
2022 A$64.88 M-45.24%
2021 A$0.11 B43.35%
2020 A$82.65 M18.51%
2019 A$69.74 M41.16%
2018 A$49.4 M-711.95%
2017 -A$8.08 Million-56.85%
2016 -A$18.72 Million-79.31%
2015 -A$90.46 Million63.85%
2014 -A$55.21 Million31.04%
2013 -A$42.14 Million-21.96%
2012 -A$53.99 Million
2010 -A$51.5 Million-42.38%
2009 -A$89.37 Million-33.56%
2008 -A$0.14 Billion65.93%
2007 -A$81.07 Million209.75%
2006 -A$26.18 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ICU Medical
ICUI
A$0.18 B-65.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-A$0.31 Billion-156.35%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
A$1.47 B 168.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B 8,807.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$12.25 B 2,137.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
A$9.63 B 1,659.69%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
A$33.87 B 6,087.41%๐Ÿ‡บ๐Ÿ‡ธ USA